title: Is primary angioplasty feasible or will we provide a two-tier service?
authors.affiliation: Cardiology Center, University Hospital, Geneva, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Chatelain
authors.forename: P
authors.initials: P
authors.lastname: Urban
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D015276:Health Care Rationing; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D010818:Practice Patterns, Physicians'; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010959:Tissue Plasminogen Activator